Atlas Trials

Superficial Basal Cell Carcinoma

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Superficial Basal Cell Carcinoma

RecordFirmDate
A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma (NCT05157763)MediWound Ltd2021-06-30
Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma (NCT04744935)Christopher Zachary2021-01-13
Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype (NCT04470726)AiViva BioPharma, Inc.2020-08-18
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT). (NCT03573401)Biofrontera Inc.2018-09-25
A Patient Decision Aid for Patients With Superficial Basal Cell Carcinoma (NCT05628714)Maastricht University Medical Center2018-01-01
Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser (NCT02270645)University of Miami2014-10-01
Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial (NCT03012009)University Hospital, Ghent2014-09-01
Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate (NCT01491711)Maastricht University Medical Center2013-08-01
PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcinoma on the Trunk or Extremities (NCT01325688)Peplin2011-04-01
Cure Rates of Superficial Basal Cell Carcinoma (BCC) EDC (NCT00994240)University of Wisconsin, Madison2008-05-01
Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma (NCT00604890)BPGbio2008-03-01
To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC (NCT00432185)Peplin2007-02-01
Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream (NCT00189306)Graceway Pharmaceuticals, LLC2001-03-01
Metvix Photodynamic Therapy (PDT) Versus Cryotherapy in Participants With Primary Superficial Basal Cell Carcinoma (NCT00469417)Galderma R&D1999-10-18

Track Superficial Basal Cell Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.